A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017

on behalf of the MD STARnet

Research output: Contribution to journalReview article

Abstract

Population studies of rare disorders, such as Duchenne and Becker muscular dystrophies (dystrophinopathies), are challenging due to diagnostic delay and heterogeneity in disorder milestones. To address these challenges, the Centers for Disease Control and Prevention established the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in 2002 in the United States. From 2002 to 2012, MD STARnet longitudinally tracked the prevalence, clinical, and health care outcomes of 1054 individuals born from 1982 to 2011 with pediatric-onset dystrophinopathy through medical record abstraction and survey data collection. This article summarizes 31 MD STARnet peer-reviewed publications. MD STARnet provided the first population-based prevalence estimates of childhood-onset dystrophinopathy in the United States. Additional publications provided insights into diagnostic delay, dystrophinopathy-specific growth charts, and health services use. Ongoing population-based surveillance continually improves our understanding of clinical and diagnostic outcomes of rare disorders.

Original languageEnglish (US)
Pages (from-to)44-53
Number of pages10
JournalJournal of Child Neurology
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Muscular Dystrophies
Pediatrics
Research
Population Surveillance
Growth Charts
Centers for Disease Control and Prevention (U.S.)
Population
Health Services
Medical Records
Publications
Delivery of Health Care

Keywords

  • dystrophinopathy
  • muscular dystrophy
  • population-based
  • public health surveillance
  • rare disorders

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017. / on behalf of the MD STARnet.

In: Journal of Child Neurology, Vol. 34, No. 1, 01.01.2019, p. 44-53.

Research output: Contribution to journalReview article

@article{b098081a73c5406d831cd12f4531fce4,
title = "A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017",
abstract = "Population studies of rare disorders, such as Duchenne and Becker muscular dystrophies (dystrophinopathies), are challenging due to diagnostic delay and heterogeneity in disorder milestones. To address these challenges, the Centers for Disease Control and Prevention established the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in 2002 in the United States. From 2002 to 2012, MD STARnet longitudinally tracked the prevalence, clinical, and health care outcomes of 1054 individuals born from 1982 to 2011 with pediatric-onset dystrophinopathy through medical record abstraction and survey data collection. This article summarizes 31 MD STARnet peer-reviewed publications. MD STARnet provided the first population-based prevalence estimates of childhood-onset dystrophinopathy in the United States. Additional publications provided insights into diagnostic delay, dystrophinopathy-specific growth charts, and health services use. Ongoing population-based surveillance continually improves our understanding of clinical and diagnostic outcomes of rare disorders.",
keywords = "dystrophinopathy, muscular dystrophy, population-based, public health surveillance, rare disorders",
author = "{on behalf of the MD STARnet} and Sahay, {Kashika M.} and Tiffany Smith and Conway, {Kristin M.} and Romitti, {Paul A.} and Lamb, {Molly M.} and Jennifer Andrews and Shree Pandya and Joyce Oleszek and Cunniff, {Christopher M} and Rodolfo Valdez",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/0883073818801704",
language = "English (US)",
volume = "34",
pages = "44--53",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017

AU - on behalf of the MD STARnet

AU - Sahay, Kashika M.

AU - Smith, Tiffany

AU - Conway, Kristin M.

AU - Romitti, Paul A.

AU - Lamb, Molly M.

AU - Andrews, Jennifer

AU - Pandya, Shree

AU - Oleszek, Joyce

AU - Cunniff, Christopher M

AU - Valdez, Rodolfo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Population studies of rare disorders, such as Duchenne and Becker muscular dystrophies (dystrophinopathies), are challenging due to diagnostic delay and heterogeneity in disorder milestones. To address these challenges, the Centers for Disease Control and Prevention established the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in 2002 in the United States. From 2002 to 2012, MD STARnet longitudinally tracked the prevalence, clinical, and health care outcomes of 1054 individuals born from 1982 to 2011 with pediatric-onset dystrophinopathy through medical record abstraction and survey data collection. This article summarizes 31 MD STARnet peer-reviewed publications. MD STARnet provided the first population-based prevalence estimates of childhood-onset dystrophinopathy in the United States. Additional publications provided insights into diagnostic delay, dystrophinopathy-specific growth charts, and health services use. Ongoing population-based surveillance continually improves our understanding of clinical and diagnostic outcomes of rare disorders.

AB - Population studies of rare disorders, such as Duchenne and Becker muscular dystrophies (dystrophinopathies), are challenging due to diagnostic delay and heterogeneity in disorder milestones. To address these challenges, the Centers for Disease Control and Prevention established the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in 2002 in the United States. From 2002 to 2012, MD STARnet longitudinally tracked the prevalence, clinical, and health care outcomes of 1054 individuals born from 1982 to 2011 with pediatric-onset dystrophinopathy through medical record abstraction and survey data collection. This article summarizes 31 MD STARnet peer-reviewed publications. MD STARnet provided the first population-based prevalence estimates of childhood-onset dystrophinopathy in the United States. Additional publications provided insights into diagnostic delay, dystrophinopathy-specific growth charts, and health services use. Ongoing population-based surveillance continually improves our understanding of clinical and diagnostic outcomes of rare disorders.

KW - dystrophinopathy

KW - muscular dystrophy

KW - population-based

KW - public health surveillance

KW - rare disorders

UR - http://www.scopus.com/inward/record.url?scp=85058837279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058837279&partnerID=8YFLogxK

U2 - 10.1177/0883073818801704

DO - 10.1177/0883073818801704

M3 - Review article

VL - 34

SP - 44

EP - 53

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 1

ER -